Novo Nordisk filed a lawsuit against rival Eli Lilly accusing it of using outdated studies to promote its GLP-1 drugs
The maker of Ozempic and Wegovy says its competitor is misleading consumers by citing outdated weight-loss data in advertisements.
The Source
TWSJ
Business
Airbus Comes for Boeing in Battle Over World’s Biggest Jets
TWSJ·1h ago·3 min read
Tech
The AI Backlash Is Starting To Sting
TWSJ·50m ago·3 min read
Business
A Luxury Taxi Company Wants to Stop New York From Tracking its Wealthy Riders
TWSJ·2h ago·3 min read
Business
Norway Oil Fund Urges Constructive Tie-Up Talks Between Prologis and Segro
TWSJ·3h ago·3 min read
Related
On this beat
Health
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
CNBC·2h ago·3 min read
Health
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
CNBC·2h ago·3 min read
Health
1,700 H.I.V. Treatment Sites Closed After Trump Aid Cuts, a Study Finds
TNYT·2h ago·3 min read
Health
Smash Chicken Caesar Tacos
WELNESS MAMA·2h ago·3 min read